Document is current

Any future updates will be listed below

Correction: Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy

Crossref DOI link: https://doi.org/10.1007/s12094-025-03867-4

Published Online: 2025-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark